News
Wednesday, 28.01.2009

Lonza reports a successful 2008

The Basel pharmaceutical supplier Lonza ended 2008 with a record performance.

Wednesday, 28.01.2009

Novartis impresses with record figures

Even in the crisis year of 2008, drug manufacturer Novartis has posted record sales and profits.

Monday, 19.01.2009

BioMedPartners raise CHF 95 million for new healthcare venture fund

BioMedPartners today announced the first closing of BioMedInvest II L.P., their second venture capital fund, at CHF 95 million.

 

Wednesday, 14.01.2009

Michael Hall awarded the Louis-Jeantet Prize for Medicine 2009

Michael N. Hall, Professor of Biochemistry at the Biozentrum, University of Basel, won the prestigious 2009 Louis-Jeantet Prize for Medicine. As one of the best endowed awards in Europe, the prize fosters scientific excellence in...

Thursday, 08.01.2009

Fresh capital for Basel biotech company Synosia

The Basel biotech company Synosia has succeeded in attracting 29 million dollars (32 million francs) from private investors

Displaying results 41 to 45 out of 81
previous Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 next